Cryo Cell International (CCEL) Receivables (2010 - 2026)

Cryo Cell International has disclosed Receivables across 17 years of filings, most recently posting $7.7 million for Q1 2026.

• In Q1 2026, Receivables fell 3.97% year-over-year to $7.7 million; the TTM figure through Feb 2026 stood at $7.7 million (down 3.97% YoY), while the FY2025 annual figure was $7.7 million, down 4.74% from the prior year.
• Receivables steadied at $7.7 million in Q1 2026, from $7.7 million in the prior quarter.
• Over the last five years, Receivables for CCEL reached as high as $15.2 million in Q2 2022 and fell as low as $5.7 million in Q1 2022.
• The 5-year median for Receivables is $7.6 million (2024), against an average of $7.8 million.
• Annual changes were most pronounced in 2022 — Receivables soared 174.68% — and 2023, when it plunged 51.57%.
• A 5-year view of Receivables shows it stood at $6.7 million in 2022, then advanced by 9.2% to $7.3 million in 2023, then advanced by 11.17% to $8.1 million in 2024, then fell by 4.74% to $7.7 million in 2025, then retreated by 0.14% to $7.7 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $7.7 million, $7.7 million, and $7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.